Leading the life sciences industry
Discover the 150+ academic medical centers, commercial labs, incubators, accelerators, and programs and services leading life sciences in New York State.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
Regeneron and Vertex Pharmaceuticals cited as Biotech Giants to Buy in 2026
New York’s Innovative Research Leads in Representation for STAT Madness 2026
Eight institutions representing New York’s biomedical ecosystem are competing in the STAT Madness bracket-style competition for the most impactful health research of the past year. Of the 50 institutions selected, New York and Massachusetts are tied for the most representation of any single state. From Manhattan’s world-renowned medical centers to the University of Rochester, the…
BIOSPHERIX LAUNCHES CENTER FOR CYTOCENTRIC® TECHNOLOGY IN PARISH, NY
Meet EXPRESS NY: A Statewide Effort to Streamline Regulations and Improve How Government Works
Governor Kathy Hochul announced the launch of EXPRESS NY (Expediting Processes and Regulations to Enable Streamlined Services), a new statewide effort to make government work better by tackling outdated and burdensome regulations, policies, and practices that stand in the way of delivering for New Yorkers. EXPRESS NY is the next phase in the governor’s 2026…
2026 Upstate Capital Impact Exchange
The Upstate Capital Impact Exchange is a one-day convening of investors, fund managers, founders, policymakers, and regional leaders focused on how regions attract, deploy, and scale early- and later-stage capital. The program highlights New York State’s investment ecosystem as a national model for how institutional and public capital can catalyze private investment and regional growth.…
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
70,000
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.
60%
PHARMACEUTICAL HEADQUARTERS